SCHEMBL1006816

SCHEMBL1006816

COC(=O)c1cc2c([nH]1)C(c1cccc(Cl)c1)CC2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 4/20 0.44
TP53 P04637 2/20 0.41
SLC6A2 P23975 1/20 0.39
LMNA P02545 1/20 0.39
POLB P06746 2/20 0.39
KMT2A Q03164 2/20 0.39
HSD17B10 Q99714 2/20 0.39
HPGD P15428 1/20 0.39
MDM2 Q00987 1/20 0.39
GAA P10253 2/20 0.38
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
GLA P06280 1/20 0.37
MAPK1 P28482 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MEN1 O00255 1/20 0.37
FFAR2 O15552 1/20 0.36
ABCB1 P08183 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1005339 0.88 LMNA (0.42) SLC6A3TP53LMNAKMT2AHPGD
SCHEMBL1003968 0.86 TSHR (0.44) SLC6A3LMNAPOLBKMT2AGAA
SCHEMBL1004641 0.86 ALDH1A1 (0.43) LMNAKMT2AALDH1A1L3MBTL1MEN1
SCHEMBL12952215 0.86 DDB1 (0.45) HPGDGAAKDM4EALDH1A1GLA
SCHEMBL2074454 0.83 CACNA1F (0.43) HSD17B10ABCB1ABCG2
SCHEMBL1002919 0.81 SLC6A3 (0.44) SLC6A3TP53SLC6A2LMNAPOLB
SCHEMBL2076153 0.80 POLB (0.44) SLC6A3SLC6A2POLBKMT2AGAA
SCHEMBL1004283 0.75 ALOX15 (0.48) TP53LMNAKMT2AHPGDGAA
SCHEMBL1003858 0.73 F7 (0.41) TP53LMNAKMT2AHPGDKDM4E
SCHEMBL2074417 0.73 HCAR2 (0.39) SLC6A3SLC6A2LMNAKMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902252-B2 Inhibitors of D-amino acid oxidase SEPRACOR, INC. (US) 2011-03-08 US disclosed
US-7902252-B2 Inhibitors of D-amino acid oxidase SEPRACOR, INC. (US) 2011-03-08 US disclosed
US-7902252-B2 Inhibitors of D-amino acid oxidase SEPRACOR, INC. (US) 2011-03-08 US disclosed
WO-2011011330-A2 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2011-01-27 WO disclosed
WO-2011011330-A2 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2011-01-27 WO disclosed
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-02-04 US disclosed
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-02-04 US disclosed
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE DDO, DAO, ACHE SLC6A3 224/4885TP53 2633/4885SLC6A2 617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.